U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
136771136771Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial SeizuresCompletedHas ResultsEpilepsies, PartialDrug: Placebo|Drug: 2400mg SPN-804|Drug: 1200mg SPN-804https://ClinicalTrials.gov/show/NCT00772603
136772136772Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell ResponseCompletedHas ResultsHIV InfectionsDrug: Raltegravir|Drug: Hyper-immune Bovine Colostrum|Other: raltegravir placebo|Other: Hyper-immune Bovine Colostrum placebo|Drug: raltegravir and hyper-immune bovine colostrumhttps://ClinicalTrials.gov/show/NCT00772590
136773136773Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 HypertensionCompletedHas ResultsHypertensionDrug: Aliskiren Hydrochlorothiazide|Drug: Ramiprilhttps://ClinicalTrials.gov/show/NCT00772577
136774136774The Use of Statins for Myocardial Death PreventionCompletedNo Results AvailableMyocardial InfarctionDrug: Atorvastatinhttps://ClinicalTrials.gov/show/NCT00772564
136775136775Raltegravir and Ezetimibe PK StudyCompletedNo Results AvailableHIVDrug: Raltegravir and ezetimibe|Drug: Ezetimibe and raltegravirhttps://ClinicalTrials.gov/show/NCT00772551
136776136776Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)CompletedHas ResultsAsthmaDrug: tiotropium 5mcg/day|Drug: placebohttps://ClinicalTrials.gov/show/NCT00772538
136777136777Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple SclerosisCompletedNo Results AvailableMultiple Sclerosis|Optic Nerve|NeuritisDrug: Nerispirdine (HP184)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00772525
136778136778A Study Of The Effect Of PF-04802540 On Sleep MeasuresCompletedNo Results AvailableHealthyDrug: PF-04802540|Drug: PF-04802540|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00772512
136779136779Vascular Improvement With Olmesartan Medoxomil StudyCompletedNo Results AvailableHypertensionDrug: olmesartan medoxomil + hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure|Drug: atenolol+ hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressurehttps://ClinicalTrials.gov/show/NCT00772499
136780136780A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLLActive, not recruitingNo Results AvailableChronic Lymphocytic LeukemiaBiological: ISF35https://ClinicalTrials.gov/show/NCT00772486
136781136781Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of MigraineCompletedNo Results AvailableHeadache, MigraineOther: subjects personal triptanhttps://ClinicalTrials.gov/show/NCT00772473
136782136782Comparison of a New Patient Warming System Using Polymer Conductive Warming With Forced Air Warming During SurgeryCompletedNo Results AvailableHypothermiaDevice: Patient Warming with conductive / convective warminghttps://ClinicalTrials.gov/show/NCT00772460
136783136783China Registration Study in Patients With Skin InfectionsCompletedHas ResultsSkin Diseases|InfectiousDrug: Daptomycin|Drug: Vancomycinhttps://ClinicalTrials.gov/show/NCT00772447
136784136784Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping InstrumentCompletedNo Results AvailableBleeding Disorderhttps://ClinicalTrials.gov/show/NCT00772434
136785136785Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - Recruitment Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - Recruitment RhythmCompletedNo Results AvailableEpilepsyDevice: There was no intervention.https://ClinicalTrials.gov/show/NCT00772421
136786136786Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary TuberculosisCompletedNo Results AvailablePulmonary Tuberculosis|Genetic Variants of Host|Immune Response of Hosthttps://ClinicalTrials.gov/show/NCT00772408
136787136787Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip ArthroplastyCompletedNo Results AvailableBone LossDrug: Risedronate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00772395
136788136788Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With HyperphosphatemiaCompletedHas ResultsChronic Kidney Disease|Dialysis|HyperphosphatemiaDrug: MCI-196https://ClinicalTrials.gov/show/NCT00772382
136789136789Retrospective Survey of Safety of Fourth Dose Pentacel® in ChildrenCompletedHas ResultsDiphtheria|Pertussis|Haemophilus Infection|Tetanus|Poliohttps://ClinicalTrials.gov/show/NCT00772369
136790136790A Monocenter, Open-Label Glucose Clamp Study Examining the Metabolic Effect of Insulin Infusion Intervals for Basal Insulin Infusion in Patients With Type I DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 1Device: Accu-Chek Spirit Insulin Pump|Device: Comparator insulin pumphttps://ClinicalTrials.gov/show/NCT00772356
136791136791Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFFâ„¢) in Subjects With Clostridium Difficile InfectionCompletedNo Results AvailableDiarrhea|Clostridium Difficile InfectionBiological: 0.9% Normal Saline|Biological: Clostridium difficile toxoid vaccine|Biological: Clostridium difficile toxoid vaccine with adjuvant|Biological: Clostridium difficile toxoid vaccinehttps://ClinicalTrials.gov/show/NCT00772343
136792136792[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT00772330
136793136793A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)RecruitingNo Results AvailableRecurrent Prostate CancerDevice: High Intensity Focused Ultrasoundhttps://ClinicalTrials.gov/show/NCT00772317
136794136794Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic RhinitisCompletedHas ResultsAllergic RhinitisDrug: Olopatadine 0.6% / Azelastine 137 mcghttps://ClinicalTrials.gov/show/NCT00772304
136795136795Chronic Pain Management After HerniorraphyCompletedNo Results AvailableChronic PainDrug: pregabalin|Drug: placebohttps://ClinicalTrials.gov/show/NCT00772291
136796136796Comparing Carotid Stenting With Endarterectomy in Severe Asymptomatic Carotid StenosisRecruitingNo Results AvailableCarotid StenosisProcedure: carotid artery stenting|Procedure: carotid endarterectomyhttps://ClinicalTrials.gov/show/NCT00772278
136797136797Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy SubjectsCompletedNo Results AvailableDiabetesBiological: Wosulin N|Biological: Novolin Nhttps://ClinicalTrials.gov/show/NCT00772265
136798136798Oxidative Stress and Microcirculation in Patient With Hepatic Failure Undergoing Liver Support TreatmentRecruitingNo Results AvailableLiver Failure|Critical CareOther: liver support treatmenthttps://ClinicalTrials.gov/show/NCT00772252
136799136799Perioperative Coagulation Management in Cardiac Surgery.TerminatedNo Results AvailableCardiac Surgery|BleedingDevice: Rotation thromboelastometry (ROTEM)|Procedure: Standard coagulation managment procedurehttps://ClinicalTrials.gov/show/NCT00772239
136800136800The Use of Music as Pain Therapy in Patients Undergoing Laparoscopic Cholecystectomy in a Day Care UnitCompletedNo Results AvailablePain|Ponv|FatigueDevice: music pillow|Device: pillow without musichttps://ClinicalTrials.gov/show/NCT00772226

* Görseller ve İçerik tekif hakkına sahip olabilir